Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
620 ARTÍCULOS , VIENDO DEL 541 AL 555
Peak SL, Gracia L, Lora G, Jinwal UK.
Neuroscience. 2021 Jan 15;453:312-323. doi: 10.1016/j.neuroscience.2020.11.020. Epub 2020 Nov 24.
New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease
Zhang F, Zhong RJ, Cheng C, Li S, Le WD.
Acta Pharmacol Sin. 2021 Sep;42(9):1382-1389. doi: 10.1038/s41401-020-00565-5. Epub 2020 Dec 2.
Role of reactive oxygen species in the progression of Alzheimer's disease
Bhatt S, Puli L, Patil CR.
Drug Discov Today. 2021 Mar;26(3):794-803. doi: 10.1016/j.drudis.2020.12.004. Epub 2020 Dec 8.
AMPK: A bridge between diabetes mellitus and Alzheimer's disease
Chen M, Huang N, Liu J, Huang J, Shi J, Jin F.
Behav Brain Res. 2021 Feb 26;400:113043. doi: 10.1016/j.bbr.2020.113043. Epub 2020 Dec 8.
Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?
Voronkov M, Cocchiaro B, Stock JB.
Neurochem Int. 2021 Feb;143:104936. doi: 10.1016/j.neuint.2020.104936. Epub 2020 Dec 10.
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng F, Edison P.
Nat Rev Neurol. 2021 Mar;17(3):157-172. doi: 10.1038/s41582-020-00435-y. Epub 2020 Dec 14.
Daily JW, Kang S, Park S.
Biofactors. 2021 Mar;47(2):218-231. doi: 10.1002/biof.1703. Epub 2020 Dec 21.
Recent Advances in Virtual Screening for Cholinesterase Inhibitors
Miles JA, Ross BP.
ACS Chem Neurosci. 2021 Jan 6;12(1):30-41. doi: 10.1021/acschemneuro.0c00627. Epub 2020 Dec 22.
Li J, Du Q, Li N, Du S, Sun Z.
Biomed Pharmacother. 2021 Mar;135:111167. doi: 10.1016/j.biopha.2020.111167. Epub 2020 Dec 29.
The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease
de Wit NM, Mol K, Rodríguez-Lorenzo S, de Vries HE, Kooij G.
Front Immunol. 2021 Jan 29;11:620348. doi: 10.3389/fimmu.2020.620348. eCollection 2020.
Thunell J, Chen Y, Joyce G, Barthold D, Shekelle PG, Brinton RD, Zissimopoulos J.
Alzheimers Dement. 2021 Jan;17(1):41-48. doi: 10.1002/alz.12175. Epub 2020 Oct 8.
Hampel H, Vergallo A, Caraci F, Cuello AC, Lemercier P, Vellas B, Giudici KV, Baldacci F, Hänisch B, Haberkamp M, Broich K, Nisticò R, Emanuele E, Llavero F, Zugaza JL, Lucía A, Giacobini E, Lista S; Alzheimer Precision Medicine Initiative.
Neuropharmacology. 2021 Mar 1;185:108081. doi: 10.1016/j.neuropharm.2020.108081. Epub 2020 May 11.
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB.
Am J Geriatr Psychiatry. 2021 Jan;29(1):51-62. doi: 10.1016/j.jagp.2020.04.026. Epub 2020 May 5.
Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE.
Am J Geriatr Psychiatry. 2021 Jan;29(1):81-89. doi: 10.1016/j.jagp.2020.05.020. Epub 2020 May 27.
Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients
Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, Mosconi L, Burns JM, Swerdlow RH.
Alzheimers Dement. 2021 Jan;17(1):7-17. doi: 10.1002/alz.12156. Epub 2020 Jul 27.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.